Skip to content

PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis

A Phase IIa Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of 14 Days' Treatment With Four Oral Doses of PA-824 in Adult Participants With Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00567840
Enrollment
69
Registered
2007-12-05
Start date
2007-08-31
Completion date
2007-12-31
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Tuberculosis

Keywords

Early Bactericidal Activity, EBA, pulmonary tuberculosis, PA-824, Pretomanid, CL-007

Brief summary

The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of PA-824 at 200, 600, 1000 and 1200 mg per day in adult patients with newly diagnosed, uncomplicated, smear positive tuberculosis. A control group will receive standard TB treatment.

Interventions

DRUGPA-824

200 mg, 600 mg, 100 mg, 1200 mg qd

Sponsors

Global Alliance for TB Drug Development
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* informed consent * M/F 18-64 yo * newly diagnosed pulmonary TB * sputum positive * adequate contraception

Exclusion criteria

* poor health * rifampicin resistance * treatment with other anti TB agents in last 3 mos. * extrapulmonary TB * COPD * neuropathy * ECG wih QRS prolongation ove 120 msec * CV disorder * diabetes requiring insulin * Metabolic disease * drug/alcohol abuse * pregnancy * use of substances that are strong inhibitors/inducers of CYP450 * use of ARV

Design outcomes

Primary

MeasureTime frame
Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).Day 0 and Day 14

Secondary

MeasureTime frame
Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).Day 0 and Day 2
Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).Day 2 and Day 14
EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)Day 0 and Day 14
EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)Day 0 and Day 2
EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]Day 2 and Day 14

Countries

South Africa

Participant flow

Participants by arm

ArmCount
PA-824 200 mg
PA-824: 200 mg per day for 14 consecutive days
15
PA-824 600 mg
PA-824: 600 mg per day for 14 consecutive days
15
PA-824 1000 mg
PA-824: 1000 mg per day for 14 consecutive days
16
PA-824 1200 mg
PA-824: 1200 mg per day for 14 consecutive days
15
Rifafour
Rifafour e-275 on Days 1 to 14, dosed by weight
8
Total69

Baseline characteristics

CharacteristicPA-824 200 mgPA-824 600 mgPA-824 1000 mgPA-824 1200 mgRifafourTotal
Age, Continuous30.5 years
STANDARD_DEVIATION 8.5
30.6 years
STANDARD_DEVIATION 9.72
31.7 years
STANDARD_DEVIATION 8.86
32.4 years
STANDARD_DEVIATION 11.51
21.9 years
STANDARD_DEVIATION 3.44
30.2 years
STANDARD_DEVIATION 9.48
Body Mass Index (BMI)20.19 kg/m^2
STANDARD_DEVIATION 4.031
20.09 kg/m^2
STANDARD_DEVIATION 3.899
19.09 kg/m^2
STANDARD_DEVIATION 2.562
19.41 kg/m^2
STANDARD_DEVIATION 3.058
17.53 kg/m^2
STANDARD_DEVIATION 1.785
19.43 kg/m^2
STANDARD_DEVIATION 3.294
Race/Ethnicity, Customized
Black
10 Participants6 Participants8 Participants8 Participants3 Participants35 Participants
Race/Ethnicity, Customized
Mixed Ethnic
5 Participants9 Participants8 Participants7 Participants5 Participants34 Participants
Sex: Female, Male
Female
8 Participants6 Participants7 Participants6 Participants4 Participants31 Participants
Sex: Female, Male
Male
7 Participants9 Participants9 Participants9 Participants4 Participants38 Participants
Weight55.3 kg
STANDARD_DEVIATION 8.58
55.9 kg
STANDARD_DEVIATION 10.51
52.5 kg
STANDARD_DEVIATION 9.82
53.5 kg
STANDARD_DEVIATION 8.48
48.0 kg
STANDARD_DEVIATION 8.7
53.6 kg
STANDARD_DEVIATION 9.36

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —
other
Total, other adverse events
6 / 154 / 155 / 167 / 152 / 8
serious
Total, serious adverse events
1 / 150 / 150 / 160 / 151 / 8

Outcome results

Primary

Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).

Time frame: Day 0 and Day 14

Population: Some of the EBA values could not be calculated due to missing results. The number of participants given are the number of participants for whom the results were available for this time period and therefore for whom the relevant EBA could be calculated.

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).0.106 log10 CFU/mlStandard Deviation 0.049
PA-824 600 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).0.107 log10 CFU/mlStandard Deviation 0.053
PA-824 1000 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).0.091 log10 CFU/mlStandard Deviation 0.083
PA-824 1200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).0.088 log10 CFU/mlStandard Deviation 0.084
RifafourEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-14).0.148 log10 CFU/mlStandard Deviation 0.055
Secondary

Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).

Time frame: Day 0 and Day 2

Population: Some of the EBA values could not be calculated due to missing results. The number of participants given are the number of participants for whom the results were available for this time period and therefore for whom the relevant EBA could be calculated.

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).0.109 log10 CFU/mlStandard Deviation 0.487
PA-824 600 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).0.096 log10 CFU/mlStandard Deviation 0.226
PA-824 1000 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).0.025 log10 CFU/mlStandard Deviation 0.34
PA-824 1200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).-0.035 log10 CFU/mlStandard Deviation 0.42
RifafourEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 0-2).0.403 log10 CFU/mlStandard Deviation 0.29
Secondary

Early Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).

Time frame: Day 2 and Day 14

Population: Some of the EBA values could not be calculated due to missing results. The number of participants given are the number of participants for whom the results were available for this time period and therefore for whom the relevant EBA could be calculated.

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).0.106 log10 CFU/mlStandard Deviation 0.063
PA-824 600 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).0.113 log10 CFU/mlStandard Deviation 0.079
PA-824 1000 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).0.095 log10 CFU/mlStandard Deviation 0.062
PA-824 1200 mgEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).0.113 log10 CFU/mlStandard Deviation 0.099
RifafourEarly Bactericidal Activity (EBA) Measured as the Daily Rate of Change in log10 CFUs (Colony Forming Units) of M. Tuberculosis in Sputum on Solid Media (Days 2-14).0.112 log10 CFU/mlStandard Deviation 0.05
Secondary

EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)

Time frame: Day 0 and Day 14

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)3.818 hours/dayStandard Deviation 2.327
PA-824 600 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)4.776 hours/dayStandard Deviation 2.879
PA-824 1000 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)4.865 hours/dayStandard Deviation 3.461
PA-824 1200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)4.440 hours/dayStandard Deviation 2.169
RifafourEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-14)9.741 hours/dayStandard Deviation 5.249
Secondary

EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)

Time frame: Day 0 and Day 2

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)1.115 hours/dayStandard Deviation 15.256
PA-824 600 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)5.788 hours/dayStandard Deviation 12.173
PA-824 1000 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)2.795 hours/dayStandard Deviation 9.23
PA-824 1200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)1.400 hours/dayStandard Deviation 7.659
RifafourEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 0-2)24.125 hours/dayStandard Deviation 12.794
Secondary

EBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]

Time frame: Day 2 and Day 14

ArmMeasureValue (MEAN)Dispersion
PA-824 200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]3.833 hours/dayStandard Deviation 2.954
PA-824 600 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]5.09 hours/dayStandard Deviation 2.768
PA-824 1000 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]4.069 hours/dayStandard Deviation 1.916
PA-824 1200 mgEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]4.868 hours/dayStandard Deviation 3.224
RifafourEBA Expressed as the Change in Time to Positive (TTP) Signal in Liquid Culture for M. Tuberculosis (Days 2-14) Show Description: [Not Specified]7.344 hours/dayStandard Deviation 4.66

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026